Revolution Medicines, Inc. (RVMD)
$211.58+1.01%Close
BUYBULL · day 18
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $45.0B
- Avg volume
- 2.8M
- Beta
- 1.40
- P/E (TTM)
- -23.88
- Short % float
- 6.06%
- Days to cover
- 6.3
- SI change
- -17.7%
- 1W
- -0.20%
- 1M
- +11.81%
- 3M
- +39.60%
- YTD
- +167.75%
- vs SPY 1W
- +0.99%
- vs SPY 1M
- +8.49%
- vs SPY 3M
- +37.21%
- vs SPY YTD
- +156.00%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- ABVXSELLAbivax S.A.BEARQ 61$116.15+1.04%
- ANNXSELLAnnexon, Inc.RECOVERYQ -7$5.06-0.20%
- CABABUYCabaletta Bio, Inc.RECOVERYQ -3$3.10-0.96%
- ERASSELLErasca, Inc.RECOVERYQ 6$17.60-0.17%
- MLTXSELLMoonLake ImmunotherapeuticsCRISISQ 4$15.37-2.47%
- MLYSSELLMineralys Therapeutics, Inc.RECOVERYQ 21$25.27-1.48%
- NDRASELLENDRA Life Sciences Inc.RECOVERYQ -20$4.56+1.56%
- PEPGBUYPepGen Inc.RECOVERYQ 1$3.19+1.59%
- PMVPBUYPMV Pharmaceuticals, Inc.RECOVERYQ -25$1.31-1.50%
- SVRASELLSavara Inc.RECOVERYQ 12$5.56-0.54%
- ANIXBUYAnixa Biosciences, Inc.RECOVERYQ 6$3.62-2.43%
- ANROBUYAlto Neuroscience, Inc.BULLQ 27$36.25+5.75%
Industry peers
FMP comparable companies · ranked by market cap
- MRNABUYModerna, Inc.$55.1BRECOVERYQ 29$138.89-4.30%
- ROIVBUYRoivant Sciences Ltd.$26.3BBULLQ 31$36.36+0.17%
- BBIOSELLBridgeBio Pharma, Inc.$15.9BRECOVERYQ 20$81.07-0.53%
- ASNDSELLAscendis Pharma A/S$15.6BRECOVERYQ 37$251.95-0.53%
- EXELSELLExelixis, Inc.$13.7BBEARQ 10$54.55+0.87%
- BMRNBUYBioMarin Pharmaceutical Inc.$12.6BBULLQ 12$65.07-2.44%
- MDGLSELLMadrigal Pharmaceuticals, Inc.$11.8BRECOVERYQ 16$511.97-0.92%
- IONSBUYIonis Pharmaceuticals, Inc.$10.3BRECOVERYQ 9$62.04+3.85%
- SMMTSELLSummit Therapeutics Inc.$10.2BCRISISQ 16$12.73-3.27%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 18
- VALUE
- 8
- GROWTH
- 45
- GARP
- 6
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-57.9%
REV YoY-
ROE-96.4%
EPS YoY-
ROA-40.9%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-23.88
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B17.12
P/FCF-
EV/EBITDA-26.43
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E24.63
ALTMAN Z-
CURR RATIO11.38
ND/EBITDA-
BETA1.40
